Product Description: Val-Cit-PABC-DOX (compound 10109), an epsilon-poly-L-lysine-based drug conjugate, is an agent-linker conjugate for ADC by using a DNA topoisomerase I and topoisomerase II inhibitor, Doxorubicin (HY-15142), linked via the linker, Val-Cit-PABC[1].
Applications: Cancer-programmed cell death
Formula: C46H56N6O16
References: [1]Furao Zhang, et al. Epsilon-poly-l-lysine-based drug conjugate, intermediate thereof, and application thereof. WO2023078464A1.
CAS Number: 1022094-34-3
Molecular Weight: 948.97
Compound Purity: 95.06
Research Area: Cancer
Target: Drug-Linker Conjugates for ADC;Topoisomerase